Candriam SCA’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-44,917
| Closed | -$1.48M | – | 825 |
|
|
2019
Q1 | $1.48M | Hold |
44,917
| – | – | 0.02% | 557 |
|
|
2018
Q4 | $2.67M | Buy |
44,917
+3,584
| +9% | +$213K | 0.04% | 401 |
|
|
2018
Q3 | $5.8M | Buy |
41,333
+27,583
| +201% | +$3.87M | 0.08% | 288 |
|
|
2018
Q2 | $1.69M | Buy |
13,750
+5,833
| +74% | +$716K | 0.03% | 521 |
|
|
2018
Q1 | $708K | Buy |
+7,917
| New | +$708K | 0.01% | 635 |
|
|
2017
Q4 | – | Sell |
-10,833
| Closed | -$458K | – | 767 |
|
|
2017
Q3 | $458K | Sell |
10,833
-3,584
| -25% | -$152K | 0.01% | 671 |
|
|
2017
Q2 | $607K | Sell |
14,417
-3,333
| -19% | -$140K | 0.01% | 641 |
|
|
2017
Q1 | $993K | Buy |
17,750
+8,750
| +97% | +$490K | 0.02% | 565 |
|
|
2016
Q4 | $343K | Hold |
9,000
| – | – | 0.01% | 636 |
|
|
2016
Q3 | $357K | Hold |
9,000
| – | – | 0.01% | 621 |
|
|
2016
Q2 | $647K | Hold |
9,000
| – | – | 0.02% | 517 |
|
|
2016
Q1 | $718K | Sell |
9,000
-1,033
| -10% | -$82.4K | 0.02% | 489 |
|
|
2015
Q4 | $757K | Hold |
10,033
| – | – | 0.02% | 420 |
|
|
2015
Q3 | $3.85M | Buy |
10,033
+1,700
| +20% | +$652K | 0.09% | 236 |
|
|
2015
Q2 | $3.46M | Hold |
8,333
| – | – | 0.07% | 288 |
|
|
2015
Q1 | $3.96M | Buy |
+8,333
| New | +$3.96M | 0.08% | 292 |
|